RUNX3 and breast cancer: Kang et al reported 5-aza-2′-deoxycytidine (5-Aza-CdR), a demethylation agent restored the expression of RUNX3, induced apoptosis and inhibited cell proliferation in the breast cancer MCF-7 cell line.